Mario A. Shields, Ph.D.
Affiliations: | 2012 | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
General Biology, Cell Biology, Molecular Biology, OncologyGoogle:
"Mario Shields"Parents
Sign in to add mentor| Hidayatullah G. Munshi | grad student | 2012 | Northwestern | |
| (The Interplay between Fibrosis and Snail Family of Transcription Factors in Pancreatic Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shields MA, Metropulos AE, Spaulding C, et al. (2023) BET inhibition rescues ciliogenesis and ameliorates pancreatitis-driven phenotypic changes in mice with Par3 loss. Biorxiv : the Preprint Server For Biology |
| Pham TN, Spaulding C, Shields MA, et al. (2022) Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity. Jci Insight. 7 |
| Shields MA, Spaulding C, Metropulos AE, et al. (2022) Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin. Cell Reports. 38: 110441 |
| Pham TND, Shields MA, Spaulding C, et al. (2021) Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers. 13 |
| Barth ND, Subiros-Funosas R, Mendive-Tapia L, et al. (2020) A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis. Nature Communications. 11: 4027 |
| Pham TND, Stempel S, Shields MA, et al. (2019) Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1. International Journal of Molecular Sciences. 20 |
| Pham T, Stempel S, Shields M, et al. (2019) Abstract 2086: Targeting the MNK effector hnRNPA1 enhances the efficacy of BET inhibitors in cancer cells Cancer Research |
| Albrengues J, Shields MA, Ng D, et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science (New York, N.Y.). 361 |
| Ebine K, Kumar K, Pham TN, et al. (2018) Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells. Scientific Reports. 8: 13225 |
| Shields M, Maguin P, Giuliano C, et al. (2018) Abstract B44: Lysyl oxidases suppress pancreatic cancer progression and inhibit FAK and ERK signaling Cancer Research. 78 |